Did your organization fund or reimburse prescription drug benefits for employees, members, or beneficiaries between May 1, 2009 and December 31, 2019? If so, your organization may be eligible to recover a share of more than $533 million in settlements arising from allegations that generic drug manufacturers conspired to fix, raise, or stabilize prices.

CLAIM FILING DEADLINE: November 9, 2026

Give us a call at (312) 204-6969 and we'll walk you through your options.

Here are the case details.

Plaintiffs allege that generic drug manufacturers conspired to fix, raise, or stablize the prices of numerous generic prescription drugs, causing consumers and organizations that funded prescription benefits to pay more than they would have in a competitive market.

Several defendants have entered settlements totaling approximately $533 million for the benefit of eligible third-party payors:

• Sandoz/Fougera: $275 million
• Sun/Taro: $200 million
• Apotex: $48 million
• Heritage: $10 million

What was the Total Fund?

$533,000,000+

When is the Claim Filing Deadline?

November 9, 2026

Who May Have a Claim?

The primary category of eligible claimants is Third-Party Payors (or TPPs). A TPP is generally a non-individual entity that indirectly paid or reimbursed some of all of the cost of eligible generic prescription drugs for its members, employees, participants, or beneficiaries.

Organizations that may qualify include:

• Health insurance companies
• Union health and welfare funds
• Taft-Hartley benefit plans
• Self-funded employers
• Employee benefit plans
• ERISA health plans
• Municipalities and counties with self-funded prescription plans
• Public universities and public health systems with self-funded plans
• Certain governmental or quasi-governmental benefit programs
• Managed-care organizations, depending on how the prescription risk was funded
• Third-party administrators or other agents authorized to file for eligible plans

The official settlement materials specifically identify insurers and employers with self-funded prescription drug plans as examples of potential TPP claimants. 

Who is Generally Not Eligible?

Potential exclusions include:

• Fully insured employers, to the extent the insurer assumed 100% of the prescription reimbursement obligation
• Pharmacy benefit amnagers filing for their own economic losses
• Purchasers that bought drugs directly from the defendant manufacturers
• Purchases made for resale
• Federal governmental entities
• Certain state governmental entities
• Medicaid agencies and certain Medicaid-related payors or purchases
• Defendants and their affiliates
• Entities that previously excluded themselves from a settlement
• Indiana and Ohio purchases or entities, subject to the applicable settlement definition

An organization may have both eligible and ineligible activity. For example, an employer that was fully insured during part of the period but self-funded during another part may still have a claim for the self-funded period.

When are Purchases Eligible?

The broadest current purchase period is May 1, 2009 through December 31,2019. However, eligibility varies by settlement:

• Sandoz: Generally May 1, 2009 - December 31, 2019
• Sun/Taro: Generally May 1, 2009 - December 31, 2019
• Apotex: Generally May 1, 2009 - December 31, 2019
• Heritage: Generally March 1, 2011 - April 1, 2019

Purchases must involve one or more of the generic drugs or National Drug Codes included in the applicable settlement.

What Data Will You Need To File a Claim?

The claim form requires TPPs to submit documentation or data reflecting their payments or reimbursements for eligible drugs. Relevant pharmacy data will likely include:

• National Drug Code (NDC)
• Prescription fill date
• Amount paid by the plan
• Member contribution
• Total prescription cost
• Reversal or adjustment indicators
• Plan or group identifier
• Funding arrangement
• Pharmacy benefit manager (PBM) or administrator
• Claim status
• Quantity and dosage information
• Geographic information, where required

The key figure is generally the amount funded by the TPP - not the full retail price, and not amounts paid by members, another insurer, or an excluded program.

How Can CCC Help?

The claim process is potentially valuable but operationally difficult. Many prospective claimants must locate and normalize pharmacy data that is seven to 17 years old and may be spread across multiple PBMs, insurers, TPAs, plans, mergers, and legacy systems.

CCC can help a qualified claimaint:

• Evaluate its organizational and plan structure
• Determine whether it operated self-funded prescription plans
• Identify the relevant PBMs, insurers, TPAs, and custodians of historical data
• Provide data specifications and retrieval guidance
• Consolidate data from multiple vendors and plan years
• Identify eligible NDCs and transactions
• Remove duplicates, reversals, member-paid amounts, and excluded purchases
• Calculate eligible plan-paid expenditures
• Prepare and submit the claim
• Respond to administrator questions and deficiencies
• Track the claim through review and distribution
• Reconcile and process any resulting payment

The court-approved allocation materials expressly contemplate claims being submitted by authorized agents, including TPAs, ASO providers, PBMs, claim aggregators, and other authorized representatives.

Want to Learn More?

Give us a call at (312) 204-6969 or email us.

About Certificate Clearing Corporation

Founded in 1993, CCC is the leader in the class action settlement recovery industry. We have helped millions of claimants recover funds in thousands of class actions. Our expert staff can help you understand the history of this litigation, its complexities, and your options for accelerated recovery. We know there is no one-size-fits-all solution, and our team is ready to customize a recovery that best suits your organization.